Potential availability of saliva-based reverse transcription-quantitative polymerase chain reaction in extensive screening for asymptomatic individuals as a business continuity strategy during the coronavirus disease 2019 pandemic - 24/04/24

Noriko Tomita ^a, Moto Kimura ^{a, ⁎} , Yukari Uemura ^a, Yukumasa Kazuyama ^b, Masato Ikeda ^b, Wataru Sugiura ^a

^a Center for Clinical Sciences, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku-ku, 162-8655, Tokyo, Japan 

^b SB Coronavirus Inspection Center Corp., 1-7-1, Kaigan, Minato-ku, Tokyo, 105-0022, Japan 

^⁎Corresponding author at: Center for Clinical Sciences, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan.Center for Clinical SciencesNational Center for Global Health and Medicine1-21-1 Toyama, Shinjuku-kuTokyo162-8655Japan

Le texte complet de cet article est disponible en PDF.